Could a patch boost arousal? new study tests At-Home nerve zapping for women

NCT ID NCT06932302

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study from the University of Michigan is testing whether a non-invasive nerve stimulation device, used at home, can improve sexual arousal in women with female sexual dysfunction. Twenty-four participants will use the UCon patch system to stimulate the dorsal genital nerve, while some will also use a smart vibrator for comparison. The main goal is to see if women can follow the treatment schedule and if it helps with arousal symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Electrical stimulation device (UCon patch system) and smart vibrator
What this could lead to
If successful, this could offer a non-invasive, at-home treatment option to improve sexual arousal symptoms in women.
What could go wrong
This is a very small pilot study (24 participants) focused on feasibility, not proof of effectiveness. The device may cause minor side effects like skin irritation or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMALE SEXUAL DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Michigan

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.